CompletedNot Applicable

Patient Outcomes After Hepatic Artery Infusion Pump Placement

United States12 participantsStarted 2022-07-12

Plain-language summary

The purpose of this study is to evaluate the surgical outcomes and the quality of life (QOL) in patients undergoing hepatic artery infusion pump placement for colorectal liver metastases (CRLM).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who receive a Hepatic Artery Infusion Pump at Mayo Clinic Rochester for liver metastases from colorectal cancer. * Written consent. Exclusion Criteria: * Absence of written consent. * Systemic disease. * Pregnancy.

What they're measuring

Quality of Life

Timeframe: Baseline prior to surgery.

Quality of Life

Timeframe: Postoperative day 2.

Quality of Life

Timeframe: Postoperative day 7.

Quality of Life

Timeframe: Postoperative day 14.

Quality of Life

Timeframe: Postoperative day 30.

Quality of Life

Timeframe: Postoperative day 60.

Quality of Life

Timeframe: Postoperative day 90.

Quality of Life

Timeframe: Postoperative day 120.

Quality of Life

Timeframe: Postoperative day 150.

Trial details

NCT IDNCT05468593

SponsorMayo Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-07-01

View on ClinicalTrials.gov More Colorectal Liver Metastases trials